List of Studies ( Metabolite:Cer 18:1;O2/21:0)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST001125 | AN001850 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacterial cells | Bacteroides ovatus | Inflammatory bowel disease | The Broad Institute,Harvard School of Public Health, Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, University of Groningen and University Medical Center Groningen, Novartis Institute for Biomedical Research Inc | Abundance |
ST001125 | AN001850 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacterial cells | Bacteroides thetaiotaomicron | Inflammatory bowel disease | The Broad Institute,Harvard School of Public Health, Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, University of Groningen and University Medical Center Groningen, Novartis Institute for Biomedical Research Inc | Abundance |
ST001127 | AN001852 | Lipid profiling of caecal samples from GF mice colonized with B. thetaiotaomicron WT or the ΔSPT mutants (part III) | Intestine | Mouse | Irritable bowel syndrome | The Broad Institute | Abundance |
ST002911 | AN004780 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | AREA |
ST002911 | AN004781 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | AREA |
ST003341 | AN005475 | Untargeted Lipidomic Profiling of Canine Cancer Cell Lines | Cultured cells | Dog | Cancer | Kojin Therapeutics, Inc. | area ratio (analyte peak area / internal class standard peak area) |
ST003222 | AN005283 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Heart | Mouse | Ischemia | University of Mississippi Medical Center | lipid content in the sample (nmol/g) |
ST003364 | AN005511 | Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease | Aortic valve tissue | Human | Heart disease | Technical University Dresden | min |
ST001950 | AN003174 | Lipidome Alterations Following Mild Traumatic Brain Injury. | Blood | Rat | Traumatic brain injury | Georgia Institute of Technology | Normalized Peak Area |
ST003239 | AN005305 | Lipidomic analysis of adipose from Gclc WT and whole-body Gclc KO mice. | Adipose tissue | Mouse | Oxidative stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Oxidative stress; Stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
ST003243 | AN005313 | Lipidomic analysis of serum from WT, liver-specific Gclc KO, liver-specific Nrf2 KO, and liver-specific Gclc-Nrf2 DKO mice. | Blood | Mouse | Oxidative stress; Stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
ST002398 | AN003905 | Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue | Muscle | Zebrafish | Myopathy | University of North Carolina at Chapel Hill | peak area |
ST002652 | AN004324 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Untargeted Lipidomics, Reversed-Phase Positive | Heart | Rat | Georgia Institute of Technology | peak area | |
ST002678 | AN004350 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Untargeted Lipidomics, Reversed-Phase Positive | Liver | Rat | Georgia Institute of Technology | peak area | |
ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | Peak Area |
ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | Peak height | |
ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | Peak height | |
ST002452 | AN004008 | Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations | Brain | Human | Dementia | The University of Sydney | pmoles/mg protein |
ST003290 | AN005389 | High expression of oleoyl-ACP-hydrolase underpins life-threatening respiratory viral diseases | Lung | Mouse | Viral infection | Peter Doherty Institute for Infection and Immunity | pmol/mg lung tissue |
ST003326 | AN005448 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | pmol/mg tissue |
ST001907 | AN003104 | Training-induced bioenergetic improvement in human skeletal muscle is associated with non-stoichiometric changes in the mitochondrial proteome without reorganisation of respiratory chain content | Muscle | Human | Baker Heart and Diabetes Institute | pmol per mg | |
ST002403 | AN003917 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Mitochondria | Rat | Kidney disease | Baker Heart and Diabetes Institute | pmol per mg |
ST003528 | AN005796 | Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma | Liver | Mouse | Cancer | University of Utah | pmol per mg tissue |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Blood | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Epididymal fat | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Liver | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |